Metrics
- Price
- $130.70
- Market Cap $M
- 17,331
- Rel Volume
- 0.79
- Vol Up 2W
- 44.4%
- Vol Trend 2W
- -41.3%
- 1D
- +0.4%
- 1W
- -1.8%
- 1M
- +30.8%
- 1M Slope
- +41.3%
- 6M Range
- 69.5%
- Score
- 82.6
- Sharp
- 6.8
Volume
Profile
Guardant Health develops blood-based diagnostic tests for cancer screening, therapy selection, and minimal residual disease monitoring using genomic analysis.
Diagnostics
Healthcare
Biotech